Literature DB >> 23754630

Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis.

Elizabeth T Jacobs1, Elizabeth A Hibler, Peter Lance, Christine L Sardo, Peter W Jurutka.   

Abstract

The relationship between the biomarker of vitamin D status, 25(OH)D, and the risk for colorectal neoplasia is suggestive but equivocal. Questions remain regarding whether there are differential associations between 25(OH)D and colorectal adenoma by gender, colorectal subsite or features of baseline and recurrent adenomas. We sought to investigate the relationship between 25(OH)D and both baseline and recurrent adenoma characteristics. Our study was conducted among 2,074 participants in a pooled population of two clinical intervention trials of colorectal adenoma recurrence. A cross-sectional analysis of 25(OH)D and baseline adenoma characteristics and a prospective study of recurrent adenomas and their characteristics were conducted. There was a statistically significant inverse association between the concentrations of 25(OH)D and the presence of three or more adenomas at baseline. Compared to participants with 25(OH)D levels of <20 ng/mL, the adjusted odds ratios (ORs) (95% condifdence intervals [CIs]) were 0.99 (0.70-1.41) for those with concentrations of ≥20 and <30 ng/mL, and 0.73 (0.50-1.06) among participants with levels of ≥30 ng/mL (p-trend = 0.05). Baseline villous histology was also significantly inversely related to 25(OH)D levels (p-trend = 0.04). Conversely, 25(OH)D concentrations were not associated with overall colorectal adenoma recurrence, with ORs (95% CIs) of 0.91 (0.71-1.17) and 0.95 (0.73-1.24; p-trend = 0.85). These findings support the concept that the relationship between vitamin D and colorectal neoplasia may vary by stage of adenoma development.
Copyright © 2013 UICC.

Entities:  

Keywords:  25(OH)D; colon cancer; colorectal adenoma; vitamin D

Mesh:

Substances:

Year:  2013        PMID: 23754630      PMCID: PMC3797158          DOI: 10.1002/ijc.28316

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  49 in total

1.  Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study.

Authors:  Veronika Fedirko; Roberd M Bostick; Michael Goodman; W Dana Flanders; Myron D Gross
Journal:  Am J Epidemiol       Date:  2010-07-22       Impact factor: 4.897

2.  Circulating vitamin D and colorectal adenomas in Japanese men.

Authors:  Ryota Takahashi; Tetsuya Mizoue; Toshie Otake; Jin Fukumoto; Osamu Tajima; Shinji Tabata; Hiroshi Abe; Keizo Ohnaka; Suminori Kono
Journal:  Cancer Sci       Date:  2010-03-23       Impact factor: 6.716

Review 3.  Epigenetics and colorectal cancer.

Authors:  Victoria Valinluck Lao; William M Grady
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-18       Impact factor: 46.802

4.  Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.

Authors:  Sara Gandini; Mathieu Boniol; Jari Haukka; Graham Byrnes; Brian Cox; Mary Jane Sneyd; Patrick Mullie; Philippe Autier
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

5.  Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies.

Authors:  Jung Eun Lee; Haojie Li; Andrew T Chan; Bruce W Hollis; I-Min Lee; Meir J Stampfer; Kana Wu; Edward Giovannucci; Jing Ma
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-23

Review 6.  Meta-analysis: Serum vitamin D and colorectal adenoma risk.

Authors:  Lu Yin; Norma Grandi; Elke Raum; Ulrike Haug; Volker Arndt; Hermann Brenner
Journal:  Prev Med       Date:  2011-06-13       Impact factor: 4.018

7.  Use of a food frequency questionnaire to screen for dietary eligibility in a randomized cancer prevention phase III trial.

Authors:  C Ritenbaugh; M Aickin; D Taren; N Teufel; E Graver; K Woolf; D S Alberts
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-05       Impact factor: 4.254

Review 8.  Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer.

Authors:  Heide S Cross; Thomas Nittke; Enikö Kallay
Journal:  Mol Cell Endocrinol       Date:  2011-07-27       Impact factor: 4.102

9.  Association between plasma 25-hydroxyvitamin D and colorectal adenoma according to dietary calcium intake and vitamin D receptor polymorphism.

Authors:  Taiki Yamaji; Motoki Iwasaki; Shizuka Sasazuki; Hiromi Sakamoto; Teruhiko Yoshida; Shoichiro Tsugane
Journal:  Am J Epidemiol       Date:  2011-12-21       Impact factor: 4.897

10.  Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps.

Authors:  Scott V Adams; Polly A Newcomb; Andrea N Burnett-Hartman; Emily White; Margaret T Mandelson; John D Potter
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

View more
  15 in total

Review 1.  Vitamin D and Gastrointestinal Cancers: A Narrative Review.

Authors:  Hemant Goyal; Abhilash Perisetti; M Rubayat Rahman; Avi Levin; Giuseppe Lippi
Journal:  Dig Dis Sci       Date:  2018-12-03       Impact factor: 3.199

2.  Plasma 25-Hydroxyvitamin D3 Levels in Colorectal Cancer Patients and Associations with Physical Activity.

Authors:  Stephanie Skender; Jürgen Böhm; Petra Schrotz-King; Jenny Chang-Claude; Erin M Siegel; Karen Steindorf; Robert W Owen; Jennifer Ose; Michael Hoffmeister; Hermann Brenner; Cornelia M Ulrich
Journal:  Nutr Cancer       Date:  2017-01-17       Impact factor: 2.900

Review 3.  Vitamin D and colon cancer.

Authors:  Lidija Klampfer
Journal:  World J Gastrointest Oncol       Date:  2014-11-15

Review 4.  Adenomas - Genetic factors in colorectal cancer prevention.

Authors:  Kycler Witold; Kubiak Anna; Trojanowski Maciej; Janowski Jakub
Journal:  Rep Pract Oncol Radiother       Date:  2018-02-09

5.  Physical activity, sedentary behavior, and vitamin D metabolites.

Authors:  Elizabeth A Hibler; Christine L Sardo Molmenti; Qi Dai; Lindsay N Kohler; Shaneda Warren Anderson; Peter W Jurutka; Elizabeth T Jacobs
Journal:  Bone       Date:  2015-11-24       Impact factor: 4.398

6.  Greater Adherence to Cancer Prevention Guidelines Is Associated with Higher Circulating Concentrations of Vitamin D Metabolites in a Cross-Sectional Analysis of Pooled Participants from 2 Chemoprevention Trials.

Authors:  Lindsay N Kohler; Elizabeth A Hibler; Robin B Harris; Eyal Oren; Denise J Roe; Peter W Jurutka; Elizabeth T Jacobs
Journal:  J Nutr       Date:  2017-01-25       Impact factor: 4.798

Review 7.  Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis.

Authors:  Yoon Ji Choi; Young Ha Kim; Chang Ho Cho; Sung Hi Kim; Jung Eun Lee
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

8.  Associations between circulating 1,25(OH)₂D concentration and odds of metachronous colorectal adenoma.

Authors:  Elizabeth A Hibler; Christine L Sardo Molmenti; Peter Lance; Peter W Jurutka; Elizabeth T Jacobs
Journal:  Cancer Causes Control       Date:  2014-04-16       Impact factor: 2.506

9.  CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence.

Authors:  Elizabeth A Hibler; Yann C Klimentidis; Peter W Jurutka; Lindsay N Kohler; Peter Lance; Denise J Roe; Patricia A Thompson; Elizabeth T Jacobs
Journal:  Nutr Cancer       Date:  2015-08-04       Impact factor: 2.900

10.  No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Serrated Polyps in a Randomized Trial.

Authors:  Mingyang Song; I-Min Lee; JoAnn E Manson; Julie E Buring; Rimma Dushkes; David Gordon; Joseph Walter; Kana Wu; Andrew T Chan; Shuji Ogino; Charles S Fuchs; Jeffrey A Meyerhardt; Edward L Giovannucci
Journal:  Clin Gastroenterol Hepatol       Date:  2020-02-13       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.